Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.60 USD | -3.01% |
|
-17.30% | -21.60% |
Feb. 04 | Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr. | DJ |
Feb. 03 | Wall Street: digesting the shock of the 'tariffs', Tesla falls 5%. | CF |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
rDNA Pharmaceuticals | ||||||||
Biotechnology | 60.21M | 803M | 18.47B | 19.26B | 6.85B | |||
Total Assets | 1.59B | 7.34B | 24.67B | 25.86B | 18.43B | |||
Interest Expense | -6.61M | -9.89M | -18M | -29M | -38M | |||
Income Tax Expense | -695K | 2.55M | 1.08B | 1.21B | 772M | |||
CAPEX | -31.55M | -67.45M | -284M | -400M | -707M | |||
EBT | -515M | -745M | 13.28B | 9.58B | -3.94B | |||
D&A | 31.02M | 93.54M | 232M | 348M | 621M | |||
Operating Income | -546M | -763M | 13.3B | 9.42B | -4.24B | |||
Net Income | -514M | -747M | 12.2B | 8.36B | -4.71B |
Geographical Revenue Distribution History
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Rest of World | - | 38.87M | 5.45B | 7.3B | 3.6B | |||
Total Assets | - | - | 10M | 37M | 259M | |||
United States | 60.21M | 765M | 6.18B | 5.15B | 1.9B | |||
Total Assets | 1.59B | 297M | 1.05B | 1.27B | 1.56B | |||
Interest Expense | -6.61M | - | - | - | - | |||
Income Tax Expense | -695K | - | - | - | - | |||
D&A | 31.02M | - | - | - | - | |||
CAPEX | -31.55M | - | - | - | - | |||
Net Income | -514M | - | - | - | - | |||
EBT | -515M | - | - | - | - | |||
Operating Income | -546M | - | - | - | - | |||
Europe | - | - | 6.85B | 6.82B | 1.36B | |||
Total Assets | - | - | 181M | 714M | 126M |
- Stock Market
- Equities
- MRNA Stock
- Financials Moderna, Inc.
- Business Segments